• About
  • Services
  • Clients
  • Client Media
    • Client News
    • Client Videos
    • CEO Insights
  • PCG Research
  • PCG Digital
    • PCG Digital Tech Watch
    • PCG Digital Biotech Watch
  • Contact
  • follow:

  • 14 Feb

    PCG Advisory Group Sponsors RHK Capital Disruptive Growth and Healthcare Conference

    NEW YORK, NY / ACCESSWIRE / February 14, 2017 / PCG Advisory Group (PCG), a leading investor and public relations firm specializing in digital and social media strategies, today announced that it is a sponsor of the upcoming RHK Capital Disruptive Growth and Healthcare Conference, taking place on February 15-16,… Read More..

    Share this:
  • 9 Feb

    PCG Advisory Group Appoints Howard Gostfrand as Senior Advisor

    NEW YORK, NY / ACCESSWIRE / February 9, 2017 / PCG Advisory Group, a New York-based leading investor and public relations firm, today announced that it has appointed Howard Gostfrand, President of American Capital Ventures, as a Senior Advisor. “Howard Gostfrand’s experience and ties to the investment community will be… Read More..

    Share this:
« Previous 1 … 37 38 39
  • PCG Advisory GroupFollow

    PCG Advisory Group
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    30 Jun

    Soligenix (NASDAQ:SNGX) Continues on Its Track by Making Progress on Milestones
    https://t.co/aaBZixC993

    Reply on Twitter 1542569911205101568Retweet on Twitter 15425699112051015689Like on Twitter 154256991120510156891Twitter 1542569911205101568
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    28 Jun

    Asensus Surgical: (NYSE American: $ASXC) Key commercial and regulatory milestones expected during the second half of 2022
    #surgicalrobotics #roboticsurgicalsystem #investors #DayTrading #investment #smallcaps
    Read our disclosures at https://t.co/RU1aW7XYbc
    https://t.co/Xxflcrbgiw

    Reply on Twitter 1541839295195058181Retweet on Twitter 1541839295195058181Like on Twitter 15418392951950581811Twitter 1541839295195058181
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    28 Jun

    Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Synthetic Hypericin in the Treatment of Psoriasis https://t.co/xjswtZ8Sk8 #biopharma #stocks #stockstowatch #stockmarket #investors #daytrader #investing #SNGX $SNGX Read our disclosures at https://t.co/RU1aW7XYbc

    Reply on Twitter 1541802097477390338Retweet on Twitter 15418020974773903381Like on Twitter 1541802097477390338Twitter 1541802097477390338
    Load More...
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client Media
      • Client News
      • Client Videos
      • CEO Insights
    • PCG Research
    • PCG Digital
      • PCG Digital Tech Watch
      • PCG Digital Biotech Watch
    • Contact